XML 67 R52.htm IDEA: XBRL DOCUMENT v3.3.1.900
Acquisitions - Receptos (Details) - USD ($)
$ / shares in Units, $ in Millions
4 Months Ended 12 Months Ended
Aug. 27, 2015
Dec. 31, 2015
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]          
Goodwill   $ 4,879.0 $ 4,879.0 $ 2,191.2  
Business Combination, Separately Recognized Transactions          
Acquisition related charges     299.6 48.7 $ 171.1
Receptos          
Business Combination, Consideration Transferred          
Total consideration $ 7,626.2        
Cash paid for outstanding common stock 7,311.3        
Cash for equity compensation attributable to pre-combination service 314.9        
Cash for the portion of equity compensation attributable to the post-combination service period 197.0        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]          
Working capital 479.2        
Property, plant and equipment 5.0        
In-process research and development product rights 6,842.0        
Current deferred tax assets 241.3        
Other non-current assets 7.9        
Non-current deferred tax liabilities(2) (2,519.2)        
Total identifiable net assets 5,056.2        
Goodwill 2,570.0        
Total net assets acquired $ 7,626.2        
Business Combination, Separately Recognized Transactions          
Expense associated with the acquisition and operations of Receptos included in Celgene's Consolidated Statements of Operation   380.5      
Acquisition related charges   19.9      
Business Acquisition, Pro Forma Information          
Total revenue     9,256.0 7,676.3  
Net income     $ 1,630.8 $ 1,499.9  
Net income per common share: basic (dollars per share)     $ 2.06 $ 1.87  
Net income per common share: diluted (dollars per share)     $ 1.98 $ 1.79  
Receptos | Research and development          
Business Combination, Separately Recognized Transactions          
Expense associated with the acquisition and operations of Receptos included in Celgene's Consolidated Statements of Operation   78.6      
Receptos | Selling, general and administrative          
Business Combination, Separately Recognized Transactions          
Expense associated with the acquisition and operations of Receptos included in Celgene's Consolidated Statements of Operation   5.1      
Receptos | Acquisition related (gains) charges and restructuring, net          
Business Combination, Separately Recognized Transactions          
Expense associated with the acquisition and operations of Receptos included in Celgene's Consolidated Statements of Operation   $ 296.8